MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Domain-specific impact of mood/anxiety disorders on quality of life in idiopathic dystonia

    D. Martino, Y. Jasaui, J. Sarna, S. Furtado, S. Patten, T. Pringsheim (Calgary, AB, Canada)

    Objective: To evaluate the relationship between mood/anxiety disorder severity and quality of life (QoL) domains in adult-onset idiopathic dystonia (AOID). Background: Depression and anxiety exert…
  • 2019 International Congress

    Drug-induced dystonia

    JB. Paredes, V. Hristova, J. Poles, S. Madrona, P. Torre, I. Moreno, S. Argos, A. Canovas, JC. Castrillo, JL. Moreno (Madrid, Spain)

    Objective: A systematic review of patients treated in the emergency department of a tertiary referral hospital for acute dystonic reactions Background: The dystonias are characterised…
  • 2019 International Congress

    Physiotherapy in cervical dystonia with focus on clinical assessments on ICF

    M. Steinboeck, H. Unger (Bad Aibling, Germany)

    Objective: It is to assess if the results of the common clinical evaluation of patients with cervical dystonia can be summarized in an objective observation…
  • 2019 International Congress

    Describing Dystonia Phenomenology and Preliminary Treatment Response in Migraine Patients

    A. Yoo, S. Bobker, S. Broner, A. Lee, G. Auerbach, L. Klebanoff, M. Vo, H. Sarva (New York, NY, USA)

    Objective: To describe dystonia phenomenology and preliminary pain response to toxin therapy in a single-center migraine cohort. Background: The co-existence of headache and craniocervical dystonia…
  • 2019 International Congress

    Hereditary spastic paraplegia 11 is easy to be misdiagnosed as adult metachromatic leukodystrophy

    S. Park, AR. Kim, N. Kim, WY. Park, JS. Kim, ES. Oh (Seoul, Republic of Korea)

    Objective: To report a case of a 32-year-old woman with progressive spastic paraparesis who was misdiagnosed initially as adult onset metachromatic leukodystrophy (MLD) Background: MLD…
  • 2019 International Congress

    The optimal connectivity profile of thalamic deep brain stimulation electrodes to effectively treat Essential Tremor

    B. Al-Fatly, S. Ewert, D. Kuebler, D. Kroneberg, A. Horn, A. Kuehn (Berlin, Germany)

    Objective: We aimed at predicting tremor improvement in essential tremor (ET) patients implanted in the area of the ventral intermediate nucleus (VIM) using brain connectivity…
  • 2019 International Congress

    Investigation of the Effects of Propranolol on DRD3, SLC1A2 and HTRA2 Gene Expression in Patients with Essential Tremor

    M. Gultekin, N. Kandemir, M. Mirza, M. Kara, N. Tascıoglu, M. Dundar (Kayseri, Turkey)

    Objective: The aim of this study investigation of the effects of gene expressions before and after propranolol treatment. Background: Essential tremor (ET) is the most…
  • 2019 International Congress

    Serum Inflammatory Profile for the Discrimination of tremor severity in essential tremor

    Z. Muruzheva, D. Traktirov, I. Ivleva, V. Maystrenko, M. Karpenko (Saint-Petersburg, Russian Federation)

    Objective: To establish the correlation between cytokines level in the serum of patients with ET and disease severity. Background: Essential tremor (ET) is the most…
  • 2019 International Congress

    The physiologic complexity of hand tremor identifies Parkinsonian tremor and essential tremor

    D. Su, Z. Liu, H. Pan, T. Feng, J. Zhou (Beijing, China)

    Objective: we hypothesize that the complexity of the hand tremor would be sensitive to and identifiable between those the PT and ET. Background: Tremor is…
  • 2019 International Congress

    Long-Term Treatment With Deutetrabenazine Is Associated With Continued Improvement in Tardive Dyskinesia: Results From an Open-Label Extension Study

    R. Hauser, H. Barkay, H. Fernandez, S. Factor, J. Jimenez-Shahed, N. Gross, M. Gordon, JM. Savola, K. Anderson (Tampa, FL, USA)

    Objective: To evaluate long-term efficacy of deutetrabenazine in patients with tardive dyskinesia (TD) by examining the change from baseline in Abnormal Involuntary Movement Scale (AIMS)…
  • « Previous Page
  • 1
  • …
  • 19
  • 20
  • 21
  • 22
  • 23
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley